The development marks an important step in Sigachi's strategic focus on expanding its presence in complex, high-value specialty APIs, aligned with global demand for advanced therapies in rare and chronic disease segments
Stevens succeeds Milton Boyer, who has stepped down as CEO but will remain closely involved with the business as an independent member of Kindeva’s Board of Directors
The BEAR Implant is the first sports medicine device to carry a label claim related to lowering PTOA risk
The grant will fund ten new J.MD projects over the next three years, targeting multiple global health threats
The MAGiC catheter is designed for robotically-navigated cardiac ablation procedures
The Toumai platform, currently the only robotic system with US FDA Study Approval for telesurgery, enabled real-time surgical control with no compromise to patient safety
Additional investments planned to expand the site’s capacity and capabilities to support growing manufacturing programs
The NP resin portfolio, indicated by its UL746G-certified prefix, equips manufacturers across industries to meet increasingly stringent regulatory and performance standards
Subscribe To Our Newsletter & Stay Updated